Specifically, gliomas produce indolamine 2,3-dioxygenase (IDO) that depletes tryptophan to shore up regulatory T cell (Tregs) levels while inhibiting CTL in the tumor milieu [112]. Here, IDO1 is linked to central nervous system cancer.